Pediatric Lupus Trial of Belimumab Plus Background Standard Therapy

NCT01649765 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

93

Enrollment

INDUSTRY

Sponsor class

Conditions

Systemic Lupus Erythematosus

Interventions

DRUG: Belimumab 10 mg/kg
OTHER: Placebo

Sponsor

GlaxoSmithKline

Collaborators

[object Object]